Ai‐Ming Yu

Shanghai Medical College of Fudan University

Also affiliated with Fudan University, University of California System, Zhongshan Hospital, Yichang Central People's Hospital, University of Pennsylvania, University of California, Davis

Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and PharmaceuticsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 32 papers. Top paper: “Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy”.

Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy

Nature Communications(2024)10.1038/s41467-023-44572-6

N/A

1.0DataRank · unranked

44 citations

Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang +11 more

Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer

Acta Pharmaceutica Sinica B(2023)10.1016/j.apsb.2023.07.011

N/A

0.507DataRank · unranked

14 citations

Mei‐Juan Tu, Fangwei Han, Zhenzhen Liu, Neelu Batra, Primo N. Lara +4 more

Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability

Drug Metabolism and Disposition(2020)10.1124/dmd.120.000207

N/A

0DataRank · unranked

27 citations

Mei‐Juan Tu, Chao Zhang, Ai‐Ming Yu, Joseph L. Jilek

Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination

Pharmacology & Therapeutics(2021)10.1016/j.pharmthera.2021.107967

N/A

0DataRank · unranked

89 citations

Mei‐Juan Tu, Ai‐Ming Yu

Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo

Acta Pharmaceutica Sinica B(2021)10.1016/j.apsb.2021.07.027

N/A

0DataRank · unranked

22 citations

Hannah Petrek, Mei‐Juan Tu, Neelu Batra, Aixi Yu, Ai‐Ming Yu +1 more

Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth

Biochemical Pharmacology(2021)10.1016/j.bcp.2020.114392

N/A

0DataRank · unranked

18 citations

Pui Yan Ho, Neelu Batra, Mei‐Juan Tu, Qianyu Zhang, Jing-Xin Qiu +2 more

A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism

Journal of Pharmacology and Experimental Therapeutics(2021)10.1124/jpet.121.000584

N/A

0DataRank · unranked

16 citations

Chao Zhang, Zhenzhen Liu, Mei‐Juan Tu, Ai-Xi Yu, Ai‐Ming Yu +1 more

Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling

Cancers(2021)10.3390/cancers13071672

N/A

0DataRank · unranked

14 citations

Zenghong Huang, Junjian Wang, Zhao Ma, Joy C. Yang, Eva Corey +4 more

Fully‐humanized bioengineered miR‐1291 modulates key nutrient transport and metabolism to exert synergistic anticancer effects with chemotherapeutics

The FASEB Journal(2021)10.1096/fasebj.2021.35.s1.02585

N/A

0DataRank · unranked

1 citations

Zhenzhen Liu, Linglong Deng, Chao Zhang, Ai‐Ming Yu, Mei‐Juan Tu

MiR‐124‐3p signaling in the control of metastasis‐related cytoskeleton organization, cell junctions and adhesion

The FASEB Journal(2021)10.1096/fasebj.2021.35.s1.02586

N/A

0DataRank · unranked

0 citations

Hannah Petrek, Mei‐Juan Tu, Ai‐Ming Yu, Linglong Deng

Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy

Pharmacological Research(2022)10.1016/j.phrs.2022.106324

N/A

0DataRank · unranked

11 citations

Yatian Yang, Zhenrui Shi, Xuesong Wu, Ruiwu Liu, Ai‐Ming Yu +2 more

MicroRNAs in the Regulation of Solute Carrier Proteins Behind Xenobiotic and Nutrient Transport in Cells

Frontiers in Molecular Biosciences(2022)10.3389/fmolb.2022.893846

N/A

0DataRank · unranked

11 citations

Ai‐Ming Yu, Colleen Yi

The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies

Cancers(2022)10.3390/cancers14040949

N/A

0DataRank · unranked

7 citations

Ashley Rowson-Hodel, Michelle Hu, Michael Keeling, Hao Wu, Kacey VanderVorst +9 more

The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations With Similar Efficiencies

Preprints.org(2022)10.20944/preprints202201.0082.v1

N/A

0DataRank · unranked

1 citations

Ashley Rowson-Hodel, Michelle Hu, Michael Keeling, Hao Wu, Kacey VanderVorst +9 more

Bioengineered miR‐34a targets MPV17L2 to control cancer cell mitochondrial functions

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r4394

N/A

0DataRank · unranked

0 citations

Wanrong Yi, Aixi Yu, Jun Lin, Ai‐Ming Yu, Mei‐Juan Tu

Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research

Drug Metabolism and Disposition(2023)10.1124/dmd.122.001008

N/A

0DataRank · unranked

13 citations

Ai‐Ming Yu, Joseph M. Cronin

Recent Advances in Novel Recombinant RNAs for Studying Post-transcriptionalGene Regulation in Drug Metabolism and Disposition

Current Drug Metabolism(2023)10.2174/1389200224666230425232433

N/A

0DataRank · unranked

4 citations

Ai‐Ming Yu, Mei‐Juan Tu

Production, structure, and function analyses of a recombinant miR-1291 agent

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.122.259220

N/A

0DataRank · unranked

0 citations

Zhenzhen Liu, Tongyi Dou, Ai‐Ming Yu, Mei‐Juan Tu

Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1423416

N/A

0DataRank · unranked

17 citations

Mei‐Juan Tu, Ai‐Ming Yu, Yimei Wang

Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents

RNA(2024)10.1261/rna.079904.123

N/A

0DataRank · unranked

10 citations

Colleen Yi, Neelu Batra, Mei‐Juan Tu, Ai‐Ming Yu, Gavin M. Traber

Molecular Engineering of Functional SiRNA Agents

ACS Synthetic Biology(2024)10.1021/acssynbio.4c00181

N/A

0DataRank · unranked

7 citations

Mei‐Juan Tu, Ai‐Ming Yu, Neelu Batra

Comparison of Three Computational Tools for the Prediction of RNA Tertiary Structures

Non-Coding RNA(2024)10.3390/ncrna10060055

N/A

0DataRank · unranked

4 citations

Mei‐Juan Tu, Gavin M. Traber, Ai‐Ming Yu, Frank Yiyang Mao

Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors

Acta Pharmaceutica Sinica B(2025)10.1016/j.apsb.2025.01.007

N/A

0DataRank · unranked

12 citations

Yatian Yang, Hongye Zou, Yang Yang, Xingling Zheng, Eva Corey +6 more

Small RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions

Frontiers in Pharmacology(2025)10.3389/fphar.2025.1720361

N/A

0DataRank · unranked

6 citations

Ai‐Ming Yu, Joseph M. Cronin

Practical Pharmacokinetic–Pharmacodynamic Models in Oncology

Pharmaceutics(2025)10.3390/pharmaceutics17111452

N/A

0DataRank · unranked

5 citations

Mei‐Juan Tu, Ai‐Ming Yu, Su Guan

Impact of Posttranscriptional Modifications in Novel Bioengineered RNAs (Abstract ID: 163872)

Journal of Pharmacology and Experimental Therapeutics(2025)10.1016/j.jpet.2024.101682

N/A

0DataRank · unranked

0 citations

Mei‐Juan Tu, Ziyuan Wang, Patrick A. Limbach, Hongxu Ding, Ai‐Ming Yu +1 more

Production and use of recombinant mirnas to dissect the intrinsic differences in miRNA biogenesis and regulation of drug metabolism and disposition

Drug Metabolism and Pharmacokinetics(2025)10.1016/j.dmpk.2025.101337

N/A

0DataRank · unranked

0 citations

Yimei Wang, Ai‐Ming Yu, Neelu Batra, Mei‐Juan Tu

A reference-guided iterative approach to polish the nanopore sequencing basecalling for therapeutic RNA quality control

Communications Biology(2025)10.1038/s42003-025-08811-4

N/A

0DataRank · unranked

0 citations

Mei‐Juan Tu, Ziyang Liu, Katherine K. Wang, Yinshan Fang, Ning Hao +6 more

Circadian regulator REV-ERBα is a master regulator of tumor lineage plasticity and an effective therapeutic target

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2513468122

N/A

0DataRank · unranked

0 citations

Yatian Yang, Hongye Zou, Demin Cai, Eva Corey, Amina Zoubeidi +5 more

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges

Pharmacological Reviews(2020)10.1124/pr.120.019554

N/A

0DataRank · unranked

401 citations

Young Hee Choi, Mei‐Juan Tu, Ai‐Ming Yu

Viral vector-free generation of orthogonal IL-2–responsive CAR T cells through gene editing of IL-2 and its receptor

Blood Immunology & Cellular Therapy(2025)10.1016/j.bict.2025.100019

N/A

0DataRank · unranked

0 citations

Yihao Wu, Jee‐Eun Yang, Kevin N. Zhou, Eric Nigel Ebenezer Anand Manoharan, Tyra Wentz +16 more

MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis

Molecular Pharmacology(2020)10.1124/molpharm.120.000130

N/A

0DataRank · unranked

36 citations

Zhijian Duan, Zhenzhen Liu, Chao Zhang, Richard J. Bold, Frank J. Gonzalez +3 more